Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.
about
Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@ast
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@en
Plasminogen activator inhibitor type-1
@nl
type
label
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@ast
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@en
Plasminogen activator inhibitor type-1
@nl
prefLabel
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@ast
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@en
Plasminogen activator inhibitor type-1
@nl
P356
P1476
Plasminogen activator inhibito ...... t for new fibrinolytic agents.
@en
P2093
P2888
P304
P356
10.1023/A:1011952602122
P577
2001-05-01T00:00:00Z
P6179
1037415223